✦ LIBER ✦

The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study

✍ Scribed by Massimo Federico; Stefano Luminari; Paolo G. Gobbi; Stefano Sacchi; Nicola Di Renzo; Marco Lombardo; Francesco Merli; Luca Baldini; Caterina Stelitano; Giovanni Partesotti; Giuseppe Polimeno; Antonella Montanini; Caterina Mammi; Maura Brugiatelli

Book ID: 114793986
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 595 KB
Volume: 76
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2005.00609.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CEOP treatment results and validity of t

CEOP treatment results and validity of the International Prognostic Index in Chinese patients with aggressive non-Hodgkin's lymphoma

✍ C. S. Chim; Y. L. Kwong; A. K. W. Lie; C. K. Lee; R. Liang 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

From 1991 to 1997, we have treated 78 newly diagnosed patients with aggressive non-Hodgkin's lymphoma with a modified CHOP regimen in which epirubicin (60 mg/m 2 ) was used in place of doxorubicin (50 mg/m 2 ), i.e. CEOP (cyclophosphamide, epirubicin, vincristine and prednisolone). The median age wa

CHOP vs. ProMACE-CytaBOM in the treatmen

CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long-term results of a multicenter randomized trial

✍ E. Montserrat; J. García-Conde; N. Viñolas; A. López-Guillermo; L. Hernández-Nie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Autologous stem cell transplantation for

Autologous stem cell transplantation for aggressive non-Hodgkin’s lymphomas in first complete or partial remission: a retrospective analysis of the outcome of 52 patients according to the age-adjusted International Prognostic Index

✍ Fanin, R; Silvestri, F; Geromin, A; Infanti, L; Sperotto, A; Cerno, M; Stocchi, 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 73 KB